GSK3B and Alzheimer disease: Increases in gliosis, oxidative stress, inflammation, and levels of Aβ, phosphorylated tau protein, and BACE1 and a decrease in the pS9-GSK3β/GSK3β ratio in the hippocampus were also observed in the 3×Tg-AD mice.